Recommendations from the European Commission Initiative on Breast Cancer on multigene tests to guide the use of adjuvant chemotherapy in patients who have hormone receptor positive, HER-2 negative, lymph node negative or up to 3 lymph nodes positive invasive breast cancer Academic Article uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Rossi, P Giorgi
  • Lebeau, A
  • Canelo-Aybar, C
  • Rivera, MC Posso
  • Comas, D Rigau
  • Quinn, C
  • Coello, P Alonso
  • McGarrigle, H
  • Warman, S
  • Broeders, M
  • Duffy, S
  • Langendam, MW
  • Gräwingholt, A
  • Follmann, M
  • Saz-Parkinson, Z
  • Schunemann, Holger

publication date

  • October 2020